Nieken, J <br/><br/>
Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update.  [electronic resource] 

 -  Cancer biotherapy & radiopharmaceuticals  Oct 1996 
 - 289-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1084-9785 
<br/><br/><label>Standard No.: </label>10.1089/cbr.1996.11.289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Renal Cell--mortality<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Outpatients<br/>Survival Rate